Paloma Pharmaceuticals
Jamaica Plain · Founded 2005
About Paloma Pharmaceuticals
Paloma Pharmaceuticals, Inc. is an early stage drug development company focusing on pathologies showing an aberrant up-regulation of the PI3K/Akt/mTOR pathway including cancer, ocular diseases (macular degeneration and diabetic retinopathy), arthritis, fibrotic diseases (renal and pulmonary fibrosis), CNS (epilepsy and neurodegenerative diseases), antiviral (HIV/AIDS) and skin diseases (psoriasis, atopic dermatitis and photodamage/wrinkling).
Company Facts
- Founded: 2005
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $1.7M
- Last round: Series Unknown (Sep 2010)
- Website: http://palomapharma.com
- Phone: +1 6174076314
Industries & Categories
Biotechnology, Health Diagnostics, Pharmaceutical
Canonical: https://fsome.com/organization/paloma-pharmaceuticals-2783346 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.